메뉴 건너뛰기




Volumn 3, Issue 4, 2007, Pages 227-232

Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol

Author keywords

25OH vitamin D; Chronic kidney disease; Dialysis; Osteomalacia; Secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; ALUMINUM; CALCIUM; CALCIUM CARBONATE; ERGOCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL; PHOSPHORUS; TETRACYCLINE; VITAMIN D;

EID: 33947622656     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0443     Document Type: Article
Times cited : (19)

References (20)
  • 1
    • 83055172414 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
    • National Kidney Foundation Kidney Disease Outcomes Quality Initiative
    • National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (Suppl 3): S1-S201
    • (2003) Am J Kidney Dis , vol.42 , Issue.SUPPL. 3
  • 2
    • 0026613738 scopus 로고
    • Vitamin D3 and calcium to prevent hip fractures in the elderly women
    • Chapuy MC et al. (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327: 1637-1642
    • (1992) N Engl J Med , vol.327 , pp. 1637-1642
    • Chapuy, M.C.1
  • 3
    • 0017653146 scopus 로고
    • 3 in the osteomalacia of chronic renal failure
    • 3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 52: 499-508
    • (1977) Clin Sci Mol Med , vol.52 , pp. 499-508
    • Eastwood, J.B.1
  • 4
    • 0033031374 scopus 로고
    • Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    • Ghazali A et al. (1995) Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55: 2169-2177
    • (1995) Kidney Int , vol.55 , pp. 2169-2177
    • Ghazali, A.1
  • 5
    • 6844257551 scopus 로고    scopus 로고
    • Hypovitaminosis D in medical inpatients
    • Thomas MK et al. (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338: 777-783
    • (1998) N Engl J Med , vol.338 , pp. 777-783
    • Thomas, M.K.1
  • 6
    • 2642546598 scopus 로고    scopus 로고
    • Prevalence of vitamin D deficiency among healthy adolescents
    • Gordon CM et al. (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158: 531-537
    • (2004) Arch Pediatr Adolesc Med , vol.158 , pp. 531-537
    • Gordon, C.M.1
  • 7
    • 0029017882 scopus 로고
    • Serum vitamin D concentrations among elderly people in Europe
    • van der Wielen RP et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210
    • (1995) Lancet , vol.346 , pp. 207-210
    • van der Wielen, R.P.1
  • 8
    • 10644280669 scopus 로고    scopus 로고
    • Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study
    • González EA et al. (2004) Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observational study. Am J Nephrol 24: 503-510
    • (2004) Am J Nephrol , vol.24 , pp. 503-510
    • González, E.A.1
  • 9
    • 20444428708 scopus 로고    scopus 로고
    • Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States
    • LaClair RE et al. (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033
    • (2005) Am J Kidney Dis , vol.45 , pp. 1026-1033
    • LaClair, R.E.1
  • 10
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
    • Levin A et al. (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38
    • (2007) Kidney Int , vol.71 , pp. 31-38
    • Levin, A.1
  • 11
    • 0023506492 scopus 로고
    • Childhood uremic bone disease
    • Langman C (1987) Childhood uremic bone disease. Pediatr Ann 16: 974-978
    • (1987) Pediatr Ann , vol.16 , pp. 974-978
    • Langman, C.1
  • 12
    • 0004109723 scopus 로고
    • Renal osteodystrophy in children: Etiology and clinical aspects
    • Eds Fine RN and Gruskin AB Philadelphia: WB Saunders
    • Mehls O (1984) Renal osteodystrophy in children: etiology and clinical aspects. In End Stage Renal Disease in Children, 227-250 (Eds Fine RN and Gruskin AB) Philadelphia: WB Saunders
    • (1984) End Stage Renal Disease in Children , pp. 227-250
    • Mehls, O.1
  • 13
    • 0036307172 scopus 로고    scopus 로고
    • Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health
    • Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9: 87-98
    • (2002) Curr Opin Endocrinol Diabetes , vol.9 , pp. 87-98
    • Holick, M.F.1
  • 14
    • 0035320323 scopus 로고    scopus 로고
    • Vitamin D nutrition and bone disease in adults
    • Mawer EB and Davies M (2001) Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Disord 2: 153-164
    • (2001) Rev Endocr Metab Disord , vol.2 , pp. 153-164
    • Mawer, E.B.1    Davies, M.2
  • 15
    • 0026033899 scopus 로고
    • Extrarenal production of calcitriol in normal and uremic humans
    • Dusso AS et al. (1991) Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72: 157-164
    • (1991) J Clin Endocrinol Metab , vol.72 , pp. 157-164
    • Dusso, A.S.1
  • 16
    • 0018691473 scopus 로고
    • Comparison of 1 alpha- hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization
    • Fournier A et al. (1979) Comparison of 1 alpha- hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int 15: 196-204
    • (1979) Kidney Int , vol.15 , pp. 196-204
    • Fournier, A.1
  • 17
    • 0031012999 scopus 로고    scopus 로고
    • How important is vitamin D deficiency in uraemia?
    • Cunningham J and Makin H (1997) How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant 12: 16-18
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 16-18
    • Cunningham, J.1    Makin, H.2
  • 18
    • 31644439542 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy
    • Coen G et al. (2005) 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 68: 1840-1848
    • (2005) Kidney Int , vol.68 , pp. 1840-1848
    • Coen, G.1
  • 19
    • 17544389564 scopus 로고    scopus 로고
    • Renal osteodystrophy in dialysis patients: Diagnosis and treatment
    • Fournier A et al. (1998) Renal osteodystrophy in dialysis patients: diagnosis and treatment. Artif Organs 22: 530-557
    • (1998) Artif Organs , vol.22 , pp. 530-557
    • Fournier, A.1
  • 20
    • 0028035183 scopus 로고
    • Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
    • Goodman WG et al. (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160-1166
    • (1994) Kidney Int , vol.46 , pp. 1160-1166
    • Goodman, W.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.